These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 8002147)

  • 41. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
    Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
    Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
    Santos DA; Hamdan JS
    Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring treatment and antifungal resistance in an outbreak of tinea caused by Microsporum audouinii.
    Johansen CD; Shen JJR; Astvad KMT; Jemec GBE; Christensen JJ; Saunte DML
    Mycoses; 2024 Jul; 67(7):e13760. PubMed ID: 38943042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigation of the agents and risk factors of dermatophytosis: a hospital-based study].
    Gürcan S; Tikveşli M; Eskiocak M; Kiliç H; Otkun M
    Mikrobiyol Bul; 2008 Jan; 42(1):95-102. PubMed ID: 18444566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fungal infection as a cause of skin disease in the eastern province of Saudi Arabia: tinea corporis and tinea cruris.
    al-Sogair SM; Moawad MK; al-Humaidan YM
    Mycoses; 1991; 34(9-10):423-7. PubMed ID: 1820522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant Trichophyton rubrum.
    de Oliveira Lima MI; Araújo de Medeiros AC; Souza Silva KV; Cardoso GN; de Oliveira Lima E; de Oliveira Pereira F
    J Mycol Med; 2017 Jun; 27(2):195-202. PubMed ID: 28189377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
    Uchida K; Hosaka J; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dermatophytosis of children in Kuwait: a prospective survey.
    al-Fouzan AS; Nanda A; Kubec K
    Int J Dermatol; 1993 Nov; 32(11):798-801. PubMed ID: 8270336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterizing the clinical isolates of dermatophytes in Hamadan city, Central west of Iran, using PCR-RLFP method.
    Farokhipor S; Ghiasian SA; Nazeri H; Kord M; Didehdar M
    J Mycol Med; 2018 Mar; 28(1):101-105. PubMed ID: 29439839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris.
    Parent D; Decroix J; Heenen M
    Dermatology; 1994; 189(4):378-81. PubMed ID: 7873824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro susceptibility of dermatophytes from Munich to griseofulvin, miconazole and ketoconazole.
    Korting HC; Rosenkranz S
    Mycoses; 1990 Mar; 33(3):136-9. PubMed ID: 2359418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
    Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new mutation in the SQLE gene of Trichophyton mentagrophytes associated to terbinafine resistance in a couple with disseminated tinea corporis.
    Hsieh A; Quenan S; Riat A; Toutous-Trellu L; Fontao L
    J Mycol Med; 2019 Dec; 29(4):352-355. PubMed ID: 31611164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Observation of a case of dermatomycosis over a 25-year period. A contribution to the discussion of the concept of griseofulvin resistance].
    Kamp W; Schirren C
    Mykosen; 1986 May; 29(5):210-20. PubMed ID: 3736589
    [No Abstract]   [Full Text] [Related]  

  • 56. Terbinafine-resistant strain of Trichophyton interdigitale strain isolated from a tinea pedis patient.
    Hiruma J; Kitagawa H; Noguchi H; Kano R; Hiruma M; Kamata H; Harada K
    J Dermatol; 2019 Apr; 46(4):351-353. PubMed ID: 30768808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dermatophytes growth curve and in vitro susceptibility test: a broth micro-titration method.
    Alió AB; Mendoza M; Zambrano EA; Díaz E; Cavallera E
    Med Mycol; 2005 Jun; 43(4):319-25. PubMed ID: 16110777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The frequency of tinea pedis in patients with tinea cruris in Tehran, Iran.
    Sadri MF; Farnaghi F; Danesh-Pazhooh M; Shokoohi A
    Mycoses; 2000; 43(1-2):41-4. PubMed ID: 10838845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
    Barros MEDS; Santos DA; Hamdan JS
    J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
    Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
    Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.